These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 980092)
1. Hew review panel on new drug regulation. Dorsen N N Engl J Med; 1976 Dec; 295(24):1383-4. PubMed ID: 980092 [No Abstract] [Full Text] [Related]
2. Washington Report. Drug Regulation Reform. Greenberg DS N Engl J Med; 1978 Apr; 298(17):979-80. PubMed ID: 642986 [No Abstract] [Full Text] [Related]
3. The Orphan Products Board of the Department of Health & Human Services. Crooks GM Prog Clin Biol Res; 1985; 197():19-23. PubMed ID: 4070294 [No Abstract] [Full Text] [Related]
4. Knowledge is power: legislative control of drug industry trade secrets. O'Reilly JT Spec Law Dig Health Care (Mon); 1987 May; 8(15):7-31. PubMed ID: 10281981 [No Abstract] [Full Text] [Related]
5. Bill may curb physician's right to prescribe. Harvey MW; Keller SE Leg Aspects Med Pract; 1978 Sep; 6(9):27-30. PubMed ID: 750818 [No Abstract] [Full Text] [Related]
6. Doctors are focus of some sweeping changes being dusted off in Drug Reform Act. Hornett P Leg Aspects Med Pract; 1978 Aug; 6(8):54-7. PubMed ID: 703483 [No Abstract] [Full Text] [Related]
7. Drug Regulation Reform Act of 1978. Greenberg RB Am J Hosp Pharm; 1978 Jun; 35(6):729-32. PubMed ID: 665689 [TBL] [Abstract][Full Text] [Related]
8. HEW planning voluntary national standards for medical radiation technologists. Radiol Technol; 1979; 51(1):101-3. PubMed ID: 472219 [No Abstract] [Full Text] [Related]
10. Medical watergate? Critics charge a cover-up at HEW of faulty research. Born RC Barrons; 1978 Oct; 58(43):9-10, 17-8. PubMed ID: 10238964 [No Abstract] [Full Text] [Related]
11. What's new in the regulation of health hazards. Clayton FW Proc Annu Meet U S Anim Health Assoc; 1978; (82):362-79. PubMed ID: 287102 [No Abstract] [Full Text] [Related]
12. Panel recommends independence, more resources for FDA. Am J Hosp Pharm; 1991 Aug; 48(8):1632, 1639. PubMed ID: 1897535 [No Abstract] [Full Text] [Related]
13. [Orphan drugs]. Galeffi C Ann Ist Super Sanita; 1991; 27(2):341-3. PubMed ID: 1661568 [TBL] [Abstract][Full Text] [Related]
14. Promoting public health and protecting consumers in a global economy: an overview of HHS/FDA's international activities. Kelly DP; Bachorik LL Food Drug Law J; 2005; 60(3):339-46. PubMed ID: 16304741 [No Abstract] [Full Text] [Related]
15. The Mega-Proposal: comprehensive HEW simplification and reform. Other HEW activities: planning, advocacy, data systems, and regulation. Policy Anal; 1975; 1(2):428-38. PubMed ID: 1235892 [No Abstract] [Full Text] [Related]
16. New Food and Drug Administration-based oversight over genetic testing. Press RD Mol Diagn; 2001 Dec; 6(4):348-9. PubMed ID: 11837221 [No Abstract] [Full Text] [Related]
18. The IRB as deputy sheriff: proposed FDA regulation of the institutional review board. Huff TA Clin Res; 1979 Apr; 27(2):103-8. PubMed ID: 10241072 [No Abstract] [Full Text] [Related]
19. The changing face of public health. Lee PR Internist; 1995 May; 36(5):14-7. PubMed ID: 10142208 [No Abstract] [Full Text] [Related]
20. Recruiting human subjects without IRB review/approval. Maloney DM Hum Res Rep; 2002 Aug; 17(8):3. PubMed ID: 12731493 [No Abstract] [Full Text] [Related] [Next] [New Search]